Biocon Ltd. — Capital/Financing Update 2025

Jun 19, 2025

==> picture [132 x 53] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com

BIO/SECL/EA/2025-26/45

June 19, 2025

To The Manager, BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street,Mumbai – 400 001	To The Manager, National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050
Scrip Code - 532523	Scrip Symbol - BIOCON

Dear Sir/ Madam,

Subject: Disclosure of the details of allotment in the Issue (as defined hereinafter) by the Biocon Limited (the “Company”) in accordance with the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements), 2015, as amended (“SEBI Listing Regulations”).

Subject: Qualified Institutions Placement of equity shares of face value ₹ 5 each (“Equity Shares”) (such placement, the “Issue”) by Biocon Limited (the “Company”) under Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”) and Sections 42, 23(1)(b) and 62(1)(c) of the Companies Act, 2013, as amended.

In continuation of our earlier letters dated June 16, 2025 and June 19, 2025 on the captioned subject, we wish to inform you that, in respect of the Issue, the Fund Raising Committee (“ Committee ”) at its meeting held today, i.e., Thursday, June 19, 2025, has inter alia , approved the issue and allotment of 136,363,635 Equity Shares of face value of ₹ 5 each to eligible qualified institutional buyers at the issue price of ₹ 330 per Equity Share (including a premium of Rs. 325 per Equity Share), aggregating to ₹ 45,000 Million (Rupees Forty Five Thousand Million) pursuant to the Issue.

The Issue opened on Monday, June 16, 2025 and closed on Thursday, June 19, 2025 and the same was intimated to you through our letters dated June 16, 2025 and June 19, 2025, respectively.

Pursuant to the allotment of Equity Shares in the Issue, the paid-up Equity Share capital of the Company stands increased from ₹ 60,03,000,000 consisting of 1,20,06,00,000 Equity Shares to ₹ 6,68,48,18,175 consisting of 1,33,69,63,635 Equity Shares of face value ₹ 5 each. The shareholding pattern of the Company before and after the Issue, will be submitted along with listing application in the format specified in Regulation 31 of the SEBI Listing Regulations.

==> picture [132 x 53] intentionally omitted <==

Further, find attached herewith the list of allottees who have been allotted more than 5% of the Equity Shares offered in the Issue, marked as Annexure 1.

The information as required under Regulation 30 of the SEBI Listing Regulations read with Schedule – III part- A to the SEBI Listing Regulations and SEBI Master circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, each as amended is as follows:

Type of securities issued and allotted (viz. equity shares, convertibles etc.)	Equity Shares
Type of Issuance (further public offering, rights issue, depository receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.)	Qualified Institutions Placement
Total no. of securities issued	136,363,635 Equity Shares of face value ₹ 5 each at a price of ₹ 330 per Equity Share (including a premium of ₹ 325per EquityShare)
Total amount for which the securities have been issued(approximately)	₹ 45,000 Million (Rupees Forty Five Thousand Million)

The meeting of the Committee commenced at 11:45 PM and concluded at 11:55 PM.

Further, as informed vide our letter dated June 16, 2025, the trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading (‘the Code’) of the Company which was already closed for the purpose of the Issue, shall open on Sunday, June 22, 2025.

We request you to kindly take this on records, and the same be treated as compliance under the applicable regulations of the SEBI Listing Regulations.

Kindly take the same on record and acknowledge.

Thanking You,

Yours faithfully,

For Biocon Limited

SIDDHA Digitally signed by SIDDHARTH RTH MITTAL Date: 2025.06.19 MITTAL 23:57:11 +05'30'

---

Siddharth Mittal Managing Director & CEO DIN: 03230757

Encl. as above

==> picture [132 x 53] intentionally omitted <==

Annexure 1

LIST OF ALLOTTEES WHO HAVE BEEN ALLOTTED MORE THAN 5% OF THE EQUITY SHARES OFFERED IN THE ISSUE

Sr No.	Name of the Allottees	No. of Shares Allotted	% of Total Issue	Percentage (PAN Clubbed) (5 % and above)
1	ICICI PRUDENTIAL VALUE DISCOVERY FUND	8,870,873	6.5053%	15.3889%
2	ICICI PRUDENTIAL PHARMA HEALTHCARE AND DIAGANOSTICS (P.H.D)FUND	6,390,844	4.6866%
3	ICICI PRUDENTIAL EQUITY SAVINGS FUND	3,815,429	2.7980%
4	ICICI PRUDENTIAL MULTICAP FUND	1,907,715	1.3990%
5	SBI CONTRA FUND	9,166,679	6.7222%	15.3889%
6	SBI MAGNUM MIDCAP FUND	6,969,697	5.1111%
7	SBI CONSERVATIVE HYBRID FUND	3,030,303	2.2222%
8	SBI MAGNUM GLOBAL FUND	1,818,182	1.3333%
9	HDFC LIFE INSURANCE COMPANY LIMITED	10,606,060	7.7778%	7.7778%
10	ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE FRONTLIN	3,855,671	2.8275%	7.2222%
11	ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C - ADITYA BIRLA SUN LIFE ELSS T	1,872,754	1.3734%
12	ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE BALANCED	727,070	0.5332%
13	ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE EQUITY A	881,296	0.6463%
14	ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE EQUITY H	660,972	0.4847%
15	ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE PHARMA &	418,615	0.3070%
16	ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE SPECIAL	264,389	0.1939%
17	ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE MULTI-CA	991,458	0.7271%
18	ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE REGULAR	176,259	0.1293%
19	NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA MULTI CAP FUND	6,676,938	4.8964%	7.2222%
20	NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA INNOVATION FUND	918,079	0.6733%
21	NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA FOCUSED EQUITY FUND	584,232	0.4284%
22	NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUND	1,669,235	1.2241%
23	MIRAE ASSET LARGE & MIDCAP FUND	3,194,103	2.3423%	7.2222%
24	MIRAE ASSET MULTICAP FUND	621,076	0.4555%
25	MIRAE ASSET LARGE CAP FUND	2,129,402	1.5616%
26	MIRAE ASSET MIDCAP FUND	2,395,577	1.7568%
27	MIRAE ASSET ELSS TAX SAVER FUND	1,064,701	0.7808%
28	MIRAE ASSET HEALTHCARE FUND	443,625	0.3253%

==> picture [132 x 53] intentionally omitted <==

Sr No.	Name of the Allottees	No. of Shares Allotted	% of Total Issue	Percentage (PAN Clubbed) (5 % and above)
29	FRANKLIN INDIA PRIMA FUND	5,862,280	4.2990%	6.6667%
30	FRANKLIN INDIA OPPORTUNITES FUND	1,881,179	1.3795%
31	FRANKLIN INDIA MULTI CAP FUND	1,347,450	0.9881%